Crohn's disease
Galapagos Drops Jyseleca in Europe, Lowers Sales Outlook
SG Tylor
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
SG Tylor
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
